Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT07017114
What this trial is testing

Pentoxifylline PKB171 Gel in Healthy Females Volunteers

Who this might be right for
SafetyPharmacokineticsMaximum Tolerated Dose
Prokrea BCN, S.L. 30
Early research (Phase 1)Study completedNCT03787498
What this trial is testing

PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Who this might be right for
Relapsed Acute Myeloid Leukemia (AML)Refractory Acute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome (MDS)
Opna Bio LLC 22
Early research (Phase 1)Study completedNCT01202214
What this trial is testing

Repeat Dose Safety Study for Compound to Treat Asthma

Who this might be right for
Asthma
Accenture
Early research (Phase 1)Study completedNCT01440699
What this trial is testing

Study of Allogenic Adipose-derived Stem Cells in Crohn's Fistula

Who this might be right for
Crohn
Anterogen Co., Ltd. 6
Early research (Phase 1)Study completedNCT00119171
What this trial is testing

Ispinesib In Combination With Capecitabine In Patients With Solid Tumors

Who this might be right for
Solid Tumor Cancer
GlaxoSmithKline 30
Early research (Phase 1)WithdrawnNCT00661336
What this trial is testing

A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Duke University
Testing effectiveness (Phase 2)UnknownNCT01505907
What this trial is testing

Pharmacokinetic Study of CXB909 in Healthy Male Subjects

Who this might be right for
Healthy
CeNeRx BioPharma Inc. 40
Early research (Phase 1)UnknownNCT01937455
What this trial is testing

A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 21
Early research (Phase 1)Study completedNCT00709540
What this trial is testing

A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal Women

Who this might be right for
Osteoporosis
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 40
Testing effectiveness (Phase 2)Study completedNCT03058289
What this trial is testing

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

Who this might be right for
Breast CancerHead and Neck CancerSquamous Cell Carcinoma+8 more
Intensity Therapeutics, Inc. 111
Early research (Phase 1)Study completedNCT00094159
What this trial is testing

Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors

Who this might be right for
Neoplasms
Sunesis Pharmaceuticals
Early research (Phase 1)Study completedNCT00486135
What this trial is testing

Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma

Who this might be right for
CancerLymphoma
Sanofi 118
Early research (Phase 1)Looking for participantsNCT07138196
What this trial is testing

Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft-Versus-Host Disease
Qurient Co., Ltd. 18
Early research (Phase 1)Study completedNCT01582997
What this trial is testing

A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid Tumors

Who this might be right for
Cancer
GlaxoSmithKline 12
Testing effectiveness (Phase 2)Looking for participantsNCT07554924
What this trial is testing

A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I

Who this might be right for
Spinal Muscular Atrophy 1
Lanyue Biotech (Hangzhou) Co., Ltd. 11
Very early researchNot Yet RecruitingNCT06546436
What this trial is testing

The Safety and Efficiency of a Single Dose of CARC-101C in Patients With Autoimmune Type 1 Diabetes Mellitus

Who this might be right for
Autoimmune Type 1 Diabetes Mellitus(T1DM)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 12
Early research (Phase 1)Study completedNCT00114699
What this trial is testing

Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy

Who this might be right for
HIV Infections
Human Genome Sciences Inc. 40
Early research (Phase 1)Study completedNCT03415399
What this trial is testing

Clinical Study of ET190L1 ARTEMIS™ in Relapsed, Refractory B Cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Eureka Therapeutics Inc. 4
Testing effectiveness (Phase 2)UnknownNCT05776407
What this trial is testing

Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma

Who this might be right for
Refractory or Relapsed B Cell Lymphoma
Chongqing University Cancer Hospital 12
Testing effectiveness (Phase 2)UnknownNCT02599064
What this trial is testing

Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD

Who this might be right for
Age-related Macular DegenerationSubfoveal Choroidal NeovascularizationSubretinal Scarring+1 more
RXi Pharmaceuticals, Corp. 9
Next Page